X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
TTK HEALTHCARE Fact Sheet, TTK HEALTHCARE Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE Fact Sheet   (TTKP)

Here is the latest financial fact sheet of TTK HEALTHCARE. For more details, see the TTK HEALTHCARE quarterly results and TTK HEALTHCARE share price and chart. For a sector overview, read our pharmaceuticals sector report.

TTK HEALTHCARE Price History

Price Rs 827.8
Mkt Cap Rs m 6,432
Vol '000 1.4
P/E X 32.7
P/CF X 41.3
EPS (TTM) Rs 25.3
% ch % -1.2
No. of shares m 7.77
% ch week % 5.2
% ch 1-mth % 8.2
% ch 12-mth % -13.0
52 week H/L Rs 1,110.0/722.0
(As on Jul 21, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TTK HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-10
12
Mar-11
12
Mar-12
12
Mar-13
12
Mar-14
5-Yr Chart
Click to enlarge
TTK HEALTHCARE EQUITY SHARE DATA
High Rs304473681598663 
Low Rs95255350330399 
Sales per share (Unadj.) Rs327.5400.2455.3492.0535.6 
Earnings per share (Unadj.) Rs11.819.020.118.315.9 
Diluted earnings per shareRs11.719.020.118.315.9 
Cash flow per share (Unadj.) Rs14.221.523.221.820.0 
Dividends per share (Unadj.) Rs3.504.004.004.004.00 
Adj. dividends per shareRs3.474.004.004.004.00 
Dividend yield (eoy) %1.81.10.80.90.8 
Book value per share (Unadj.) Rs84.097.5112.9126.4137.6 
Adj. book value per shareRs83.397.5112.9126.4137.6 
Shares outstanding (eoy) m7.707.777.777.777.77 
Bonus/Rights/Conversions  BB---- 
Price / Sales ratio x0.60.91.10.91.0 
Avg P/E ratio x16.919.225.625.433.3 
P/CF ratio (eoy) x14.116.922.321.326.5 
Price / Book Value ratio x2.43.74.63.73.9 
Dividend payout %29.621.119.921.925.1 
Avg Mkt Cap Rs m1,5362,8284,0053,6074,127 
No. of employees `0001.31.51.51.81.7 
Total wages/salary Rs m302368436530607 
Avg. sales/employee Rs Th1,877.92,103.72,336.52,175.92,436.7 
Avg. wages/employee Rs Th224.9249.1287.7301.4355.2 
Avg. net profit/employee Rs Th67.899.7103.280.872.5 
TTK HEALTHCARE INCOME DATA
Net Sales Rs m2,5223,1093,5373,8234,162 
Other income Rs m3844476761 
Total revenues Rs m2,5603,1533,5843,8904,223 
Gross profit Rs m152214238201197 
Depreciation Rs m1820242732 
Interest Rs m1717262530 
Profit before tax Rs m155222236216197 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m6474797473 
Profit after tax Rs m91147156142124 
Gross profit margin %6.06.96.75.34.7 
Effective tax rate %41.333.533.634.337.0 
Net profit margin %3.64.74.43.73.0 
TTK HEALTHCARE BALANCE SHEET DATA
Current assets Rs m1,1591,4821,4611,5441,629 
Current liabilities Rs m7351,0779439991,058 
Net working cap to sales %16.813.014.614.313.7 
Current ratio x1.61.41.51.51.5 
Inventory Days Days3331342630 
Debtors Days Days3338393434 
Net fixed assets Rs m303374393438556 
Share capital Rs m7878787878 
"Free" reserves Rs m454565685791878 
Net worth Rs m6477578779821,069 
Long term debt Rs m0656159 
Total assets Rs m1,5441,9291,9242,0942,399 
Interest coverage x10.113.910.29.57.6 
Debt to equity ratio x00000.1 
Sales to assets ratio x1.61.61.81.81.7 
Return on assets %7.08.59.58.06.4 
Return on equity %14.119.517.814.511.6 
Return on capital %26.631.329.624.518.5 
Exports to sales %0.70.70.71.20.8 
Imports to sales %2.11.00.91.21.4 
Exports (fob) Rs m1721264733 
Imports (cif) Rs m5432324758 
Fx inflow Rs m1721264733 
Fx outflow Rs m5636375163 
Net fx Rs m-39-15-11-4-30 
TTK HEALTHCARE CASH FLOW
From Operations Rs m 190 254 62 244 127 
From Investments Rs m -112 -71 -43 -5 -146 
From Financial Activity Rs m -88 -68 -9 -20 22 
Net Cashflow Rs m -9 115 10 218 3 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 65.4%
Foreign collaborators 0.0%
Indian inst/Mut Fund 3.7%
FIIs 5.2%
ADR/GDR 0.0%
Free float 25.8%
Shareholders 12,723
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF No.6, Cathedral Road, Chennai - 600 086
E-MAIL skr@ttkhealthcare.com WEB www.ttkhealthcare.com
TELEPHONE (044) 2811 6106 FAX (044) 2811 6387
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Data Software, 19, Pycrofts Garden Road, Nungambakkam, Chennai-06
AUDITOR Aiyar & Co.
CHM: T. T. Jagannathan COMP SEC: S. Kalyanaraman YEAR OF INC: 1958 BSE CODE: 507747 FV (Rs): 10 DIV YIELD (%): 0.5

More Pharmaceuticals Company Fact Sheets:   PIRAMAL ENTERPRISES  NATCO PHARMA  FULFORD INDIA  STRIDES SHASUN LTD  MERCK LTD  

Compare TTK HEALTHCARE With:   PIRAMAL ENTERPRISES  NATCO PHARMA  FULFORD INDIA  STRIDES SHASUN LTD  MERCK LTD  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Stronger Euro Drags European Markets(RoundUp)

The strength of the euro does appear to be acting as a bit of a headwind for European stocks as they look to close the week sharply lower in contrast to the performance of UK and US stocks this week.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

The Impact of GST On Banking transactions, Insurance, and Investments(Outside View)

Jul 11, 2017

PersonalFN explains how GST impacts your insurance premiums, investments, and banking transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - TEVA PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS